CN101780025B - Beautifying and whitening sun protection pressed powder and preparation method thereof - Google Patents
Beautifying and whitening sun protection pressed powder and preparation method thereof Download PDFInfo
- Publication number
- CN101780025B CN101780025B CN 201010148668 CN201010148668A CN101780025B CN 101780025 B CN101780025 B CN 101780025B CN 201010148668 CN201010148668 CN 201010148668 CN 201010148668 A CN201010148668 A CN 201010148668A CN 101780025 B CN101780025 B CN 101780025B
- Authority
- CN
- China
- Prior art keywords
- powder
- sun protection
- beautifying
- whitening
- lysine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000843 powder Substances 0.000 title claims abstract description 68
- 230000037072 sun protection Effects 0.000 title claims abstract description 18
- 230000002087 whitening effect Effects 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 title abstract description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 37
- 239000004472 Lysine Substances 0.000 claims abstract description 31
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims abstract description 29
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims abstract description 27
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 26
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 18
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 18
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 18
- 239000011709 vitamin E Substances 0.000 claims abstract description 18
- 229940046009 vitamin E Drugs 0.000 claims abstract description 18
- 239000004408 titanium dioxide Substances 0.000 claims abstract description 14
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 13
- 239000000203 mixture Substances 0.000 claims abstract description 12
- 238000000034 method Methods 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 230000008569 process Effects 0.000 claims abstract description 4
- 244000293323 Cosmos caudatus Species 0.000 claims description 33
- 235000005956 Cosmos caudatus Nutrition 0.000 claims description 33
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 32
- 229910052710 silicon Inorganic materials 0.000 claims description 16
- 239000010703 silicon Substances 0.000 claims description 16
- 238000002156 mixing Methods 0.000 claims description 15
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims description 12
- 229960001679 octinoxate Drugs 0.000 claims description 12
- 239000004677 Nylon Substances 0.000 claims description 9
- 229920001778 nylon Polymers 0.000 claims description 9
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims description 9
- 239000004926 polymethyl methacrylate Substances 0.000 claims description 9
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 claims description 8
- 229940073609 bismuth oxychloride Drugs 0.000 claims description 8
- 229940008099 dimethicone Drugs 0.000 claims description 8
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 8
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 8
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 8
- 239000010445 mica Substances 0.000 claims description 8
- 229910052618 mica group Inorganic materials 0.000 claims description 8
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 claims description 8
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 7
- 238000009725 powder blending Methods 0.000 claims description 6
- 239000003921 oil Substances 0.000 claims description 4
- 238000000227 grinding Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 36
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract description 33
- 235000018977 lysine Nutrition 0.000 abstract description 25
- 239000000126 substance Substances 0.000 abstract description 11
- 230000006870 function Effects 0.000 abstract description 5
- 229960003646 lysine Drugs 0.000 abstract description 4
- 230000003712 anti-aging effect Effects 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract description 3
- 229940057948 magnesium stearate Drugs 0.000 abstract description 3
- 229960005196 titanium dioxide Drugs 0.000 abstract description 3
- 230000009471 action Effects 0.000 abstract description 2
- 230000008901 benefit Effects 0.000 abstract description 2
- 230000000903 blocking effect Effects 0.000 abstract 1
- CMDKPGRTAQVGFQ-RMKNXTFCSA-N cinoxate Chemical compound CCOCCOC(=O)\C=C\C1=CC=C(OC)C=C1 CMDKPGRTAQVGFQ-RMKNXTFCSA-N 0.000 abstract 1
- 229960001063 cinoxate Drugs 0.000 abstract 1
- 235000012459 muffins Nutrition 0.000 description 13
- 235000001014 amino acid Nutrition 0.000 description 9
- 150000001413 amino acids Chemical class 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 6
- 235000020776 essential amino acid Nutrition 0.000 description 5
- 239000003797 essential amino acid Substances 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000000475 sunscreen effect Effects 0.000 description 5
- 239000000516 sunscreening agent Substances 0.000 description 5
- 235000019766 L-Lysine Nutrition 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical group O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 230000003255 anti-acne Effects 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- AFDXODALSZRGIH-QPJJXVBHSA-N (E)-3-(4-methoxyphenyl)prop-2-enoic acid Chemical class COC1=CC=C(\C=C\C(O)=O)C=C1 AFDXODALSZRGIH-QPJJXVBHSA-N 0.000 description 2
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 206010041303 Solar dermatitis Diseases 0.000 description 2
- 206010042496 Sunburn Diseases 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 229960004203 carnitine Drugs 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 239000011049 pearl Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000382825 Cristaria plicata Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010058314 Dysplasia Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 208000007117 Oral Ulcer Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 241000879903 Pteria Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- 241001532014 Xanthorrhoea Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 239000001058 brown pigment Substances 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 208000036654 deficiency anemia Diseases 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 150000004683 dihydrates Chemical class 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000007368 endocrine function Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000004005 nitrosamines Chemical class 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 210000001428 peripheral nervous system Anatomy 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000036417 physical growth Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- -1 sulfur aminoacid Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- FEPMHVLSLDOMQC-UHFFFAOYSA-N virginiamycin-S1 Natural products CC1OC(=O)C(C=2C=CC=CC=2)NC(=O)C2CC(=O)CCN2C(=O)C(CC=2C=CC=CC=2)N(C)C(=O)C2CCCN2C(=O)C(CC)NC(=O)C1NC(=O)C1=NC=CC=C1O FEPMHVLSLDOMQC-UHFFFAOYSA-N 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000012711 vitamin K3 Nutrition 0.000 description 1
- 239000011652 vitamin K3 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010148668 CN101780025B (en) | 2010-04-16 | 2010-04-16 | Beautifying and whitening sun protection pressed powder and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010148668 CN101780025B (en) | 2010-04-16 | 2010-04-16 | Beautifying and whitening sun protection pressed powder and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101780025A CN101780025A (en) | 2010-07-21 |
CN101780025B true CN101780025B (en) | 2012-06-13 |
Family
ID=42520256
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201010148668 Expired - Fee Related CN101780025B (en) | 2010-04-16 | 2010-04-16 | Beautifying and whitening sun protection pressed powder and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101780025B (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102198074B (en) * | 2011-06-08 | 2013-04-10 | 浙江欧诗漫集团有限公司 | Pearl finishing powder |
CN103340809B (en) * | 2013-06-24 | 2014-11-12 | 浙江长生鸟珍珠生物科技有限公司 | Sun-blocking skin-care product containing superfine pearl powder and preparation method of sun-blocking skin-care product |
CN103340815B (en) * | 2013-07-23 | 2014-11-05 | 陆飞 | Foundation make-up for eliminating facial edema |
CN104721106A (en) * | 2013-12-23 | 2015-06-24 | 青岛东昌源仪器有限公司 | Nutritional sun-protection compact powder capable of delaying senescence |
CN104042505B (en) * | 2014-06-17 | 2016-12-14 | 娇时日化(杭州)股份有限公司 | A kind of muffin and production technology thereof |
CN104606072A (en) * | 2014-12-31 | 2015-05-13 | 安徽恒昊科技有限公司 | Preparation method of silicone-treated sericite powder |
KR101859284B1 (en) * | 2016-09-07 | 2018-05-17 | 주식회사 엘지생활건강 | Makeup cosmetic composition with excellent skin-affinity and spreadability |
CN109091414A (en) * | 2017-06-20 | 2018-12-28 | 广州迦心化妆品有限公司 | A kind of double factory formulas and technique for repairing muffin |
CN107115228A (en) * | 2017-07-12 | 2017-09-01 | 熊廷珍 | A kind of sea urchin polysaccharide moisturizing muffin and preparation method thereof |
CN108245437A (en) * | 2018-04-16 | 2018-07-06 | 杭州心悦化妆品有限公司 | Wet-dry moistens sun protection pressed powder and preparation method thereof |
CN110215412A (en) * | 2019-06-14 | 2019-09-10 | 苏州蓓希颜化妆品股份有限公司 | Reversible sensitization discoloration composition and application, the cosmetic composition containing it |
CN110478263A (en) * | 2019-08-28 | 2019-11-22 | 上海应用技术大学 | A kind of sunscreen powders and its preparation and the application in color make-up |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1264576A (en) * | 1998-12-30 | 2000-08-30 | 莱雅公司 | Compressed powder type waterless and hydrophobic face-care compsns. |
CN1302597A (en) * | 1999-12-28 | 2001-07-11 | 花王株式会社 | Pressed cake cosmetics composition |
-
2010
- 2010-04-16 CN CN 201010148668 patent/CN101780025B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1264576A (en) * | 1998-12-30 | 2000-08-30 | 莱雅公司 | Compressed powder type waterless and hydrophobic face-care compsns. |
CN1302597A (en) * | 1999-12-28 | 2001-07-11 | 花王株式会社 | Pressed cake cosmetics composition |
Non-Patent Citations (2)
Title |
---|
朱林 译.化妆品中的功能粉体.《日用化学工业译丛》.1994,(第5期),28-31. * |
蒋人俊."干、湿两用粉饼"的研制.《日用化学工业》.1992,(第6期),9-11. |
Also Published As
Publication number | Publication date |
---|---|
CN101780025A (en) | 2010-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101780025B (en) | Beautifying and whitening sun protection pressed powder and preparation method thereof | |
KR101223682B1 (en) | Method for producing functional cosmetic composition and the cosmetic | |
CN101966142B (en) | Traditional Chinese medicinal facial mask powder for maintaining beauty and keeping young | |
CN102641233B (en) | Rhodiola crenulata facial mask with whitening and moisturizing effects | |
CN101773463A (en) | Selenium-enriched nano pearl powder formula and production method thereof | |
CN103919711B (en) | A kind of anti-ageing whitening cream of oolong tea and manufacture method thereof | |
KR101860307B1 (en) | Cosmetic composition for moisturizing skin containing water-soluble silicon | |
CN102085171A (en) | Skin-care beatifying cream | |
CN101780026B (en) | Eye shadow and eye line powder block and preparation method thereof | |
CN109248135A (en) | A kind of sheen highlights, the external-use skin care of concealing moisturizing combination and preparation method thereof | |
CN103520046B (en) | A kind of banana composite mask powder for improving looks | |
WO2020054204A1 (en) | Antioxidant | |
KR101400308B1 (en) | beverage composition and the method thereof | |
CN107048385A (en) | A kind of composition with blackening and generating hair function and preparation method thereof | |
KR101168796B1 (en) | Skin care cosmetic composition | |
CN104013549B (en) | Skin care product containing lethariella sinensis extract | |
CN106667813A (en) | Natural plant sunscreen nano emulsion | |
CN111939115A (en) | Natural plant essence repairing mask and preparation method thereof | |
CN107669607A (en) | A kind of facial mask and preparation method thereof | |
CN105832638B (en) | Whitening pearl facial mask beautifying liquid with deep water supplement moisture-keeping functions and its preparation method | |
JP2002145731A (en) | Cosmetic | |
CN112451441A (en) | Make-up cosmetic and preparation method thereof | |
CN106137942A (en) | Cosmetical face film with Chinese medicines and preparation method thereof | |
CN101991037B (en) | Angelica-aronia melanocarpa pill and manufacturing method thereof | |
CN104337752A (en) | Okra beauty mask powder and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: TIANJIN TIANSHI BIOENGINEERING CO., LTD. TIANJIN TIANSHI BIOLOGICAL DEVELOPMENT CO., LTD. TIENS GROUP CO., LTD. Effective date: 20141124 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 301700 Tianjin New Technology Industrial Park Development Zone Wuqing city Wuqing District Road No. 6 source Patentee after: TIANJIN TIANSHI BIOLOGICAL DEVELOPMENT Co.,Ltd. Patentee after: TIANJIN TIANSHI BIOLOGICAL ENGINEERING Co.,Ltd. Patentee after: TIANJIN TIANSHI LIFE-RESOURCES Co.,Ltd. Patentee after: TIENS GROUP Co.,Ltd. Address before: 301700 Tianjin New Technology Industrial Park Development Zone Wuqing city Wuqing District Road No. 6 source Patentee before: TIANJIN TIANSHI BIOLOGICAL DEVELOPMENT Co.,Ltd. Patentee before: TIANJIN TIANSHI BIOLOGICAL ENGINEERING Co.,Ltd. Patentee before: TIANJIN TIANSHI LIFE-RESOURCES Co.,Ltd. Patentee before: TIANJIN TIANSHI GROUP Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20141124 Address after: 301700 Tianjin Wuqing Xinyuan Road North, No. 18 Patentee after: TIANJIN TIANSHI BIOLOGICAL DEVELOPMENT Co.,Ltd. Address before: 301700 Tianjin New Technology Industrial Park Development Zone Wuqing city Wuqing District Road No. 6 source Patentee before: TIANJIN TIANSHI BIOLOGICAL DEVELOPMENT Co.,Ltd. Patentee before: TIANJIN TIANSHI BIOLOGICAL ENGINEERING Co.,Ltd. Patentee before: TIANJIN TIANSHI LIFE-RESOURCES Co.,Ltd. Patentee before: TIENS GROUP Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120613 |
|
CF01 | Termination of patent right due to non-payment of annual fee |